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Abstract: Introduction: Ca-125 is secreted by different celomic epitheliums. Serum levels may be increased in malignant 
diseases, like ovarian cancer but also in other medical conditions, such as pulmonary and extrapulmonary tuberculosis. 
Methods: From Jan-04 to Dec-06 a retrospective study analyzing Ca-125 levels in serum samples from patients with a 
diagnosis of pulmonary TB, was performed. These results were compared with those samples obtained from patients with 
non-TB pulmonary infections. 
Results: Eighty-nine patients were included in the study, thirty-five with pulmonary TB and 54 with other respiratory 
infections. In patients with TB, the mean Ca-125 value was 104.9 IU/ml (SD: ± 136.1). In the control group, mean value 
was 27.1 IU/ml (SD: ±19.7). The optimal cut-off for pulmonary tuberculosis was 32.5 IU/ml (sensitivity: 68.6%, 
specificity: 77.8%). Pulmonary TB was the only factor associated with a Ca-125 level >32.5. In 10 patients with TB, Ca-
125 levels were available  2 months after starting TB therapy and a decrease during treatment was shown. 
Conclusions: Ca-125 values increase in patients with pulmonary TB and decline to normal values during treatment. 
Determination of Ca 125 may be usedin patients with a negative sputum AFB stain. 
Keywords: Ca-125, tuberculosis, pneumonia. 
INTRODUCTION 
  Patients with tuberculosis (TB) present pulmonary 
involvement most frequently. Microscopic examination of 
acid-fast stained sputum smears remains the most useful 
diagnostic method and positive samples establish indications 
for initiation of TB therapy and respiratory isolation. 
However, in some cases of pulmonary TB acid-fast bacilli 
stains in sputum samples may be negative or respiratory 
specimens may not be available, and other methods have to 
be used to establish the diagnosis of TB. Apart from 
microbiological molecular diagnostic tests, different 
biochemical parameters have been proposed as helpful tools 
for this purpose, including various markers of cellular 
activity, acute phase reactants and enzymes [1-5]. 
  The tumor marker Ca-125 has been proposed as a useful 
diagnostic tool for tuberculosis. Ca-125 serum concentrat-
ions are known to rise in some benign and malignant 
diseases [6, 7]. High levels of Ca-125 have been reported in 
patients with pulmonary and extra-pulmonary tuberculosis, 
including pleural, peritoneal, pelvic, milliary, and intra-
abdominal disease. The diagnostic value of Ca-125 to help 
differentiate pulmonary tuberculosis from other pulmonary 
infections has been poorly studied [8-14]. 
  In order to asses the efficacy of Ca-125 serum levels in 
differentiating pulmonary tuberculosis from bacterial 
pneumonia and other respiratory infections in patients with 
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fever and pulmonary infiltrates, a retrospective study was 
performed. 
METHODS 
  The study was performed at the Ramón y Cajal Hospital, 
a 1000-bed tertiary referral Hospital (Madrid, Spain), during 
a three year period (January 2004 to December 2006). By 
protocol, tumoral markers determinations are included in the 
ordinary biochemical form application. They are obtained 
from all patients admitted in the unit for differential 
diagnosis purpose, including malignancy, in patients with 
lung infiltrates. 
  Ca-125 was determined by an electro-chemillumine-
scence test (Elecsys 1010, Roche), including a radioimmuno 
assay (RIA) Packard Gamma counter. 
  In all cases, tuberculosis was confirmed by positive 
culture in sputum or other tract respiratory samples. Serum 
Ca-125 levels were compared in patients with a diagnosis of 
TB infection versus patients with a diagnosis of bacterial 
pneumonia or other pulmonary infections. Patients with lung 
infiltrates related with oncologic process, heart failure, 
idiopathic interstitial pneumonitis or other non-infectious 
processes were excluded. 
  ROC curves were used to determine the optimal cut-off 
value of serum Ca-125 which could distinguish TB from 
other pulmonary infections with the highest sensitivity, 
specificity, and predictive values [15]. The curve obtained, 
allowed the calculation of the slope and the area under the 
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  For some patients in the TB group, Ca-125 was also 
measured during follow-up (2 to 4 months after starting TB 
treatment). 
  For the analysis of risk factors associated with TB 
infection, a case-control study was performed, considering 
TB patients as cases and patients with non-TB pulmonary 
infection as controls. 
  Hospital records for all patients included in both groups 
to obtain information regarding clinical, radiological, and 
outcome characteristics were examined. The association 
between categorical variables was performed using Chi-
squared tests with the Yates correction or Fisher Exact Test 
(two-tailed) as necessary. Continuous variable association 
was analysed with the Mantel-Haenszel test. Statistical 
analysis was performed with the SPSS software package 
(version 11.0; SPSS Inc, Chicago, IL). 
  Informed consent: according to the IRB, only patients’ 
oral informed consent for the anonymous treatment of their 
data is required when the sudy protocol is the same used for 
regular medical attention of these patients in our hospital. 
 
RESULTS 
  A total of 89 patients was included in the study. Thirty 
five patients had culture positive pulmonary tuberculosis and 
54 patients had other causes of fever and pulmonary 
infiltrates. 
  Patient characteristics are shown in Table 1. 
  In the control group most patients (68%, 37 patients) had 
a confirmed diagnosis of community-acquired pneumonia. 
Eight patients (15%) had chronic obstructive pulmonary 
disease (COPD) and were diagnosed of acute exacerbations 
with response to antibiotic therapy. The remaining 9 patients 
were diagnosed of nosocomial-acquired pneumonia (n=4), 
interstitial pneumonia responding to clarithromycin therapy 
(n=3), empyema (n=1) and pleuropericarditis (n=1). 
  Sixteen patients (18%) had HIV infection; of these, 9 
patients had tuberculosis and 7 patients had other pulmonary 
infections. HIV-infected patients had a median CD4 cell 
count lower than HIV-negative controls (124/ mm, range: 
12-358 vs 203 cells/mm
3
, range: 84-540), although this was 
not statistically significant. 
 
Table 1.  Characteristics of Patients with Pulmonary Tuberculosis (Cases) and Patients with Other Causes of Pulmonary Infections 
(Controls) 
 
  Cases (n=35)  Controls (n=54) 
Clinical presentation 
   -Pulmonary tuberculosis 
   -Lobar community acquired pneumonia 
   -Acute exacerbation in COPD * 
   -Nosocomial pneumonia 
   -Interstitial community acquired pneumonia # 
   -Empyema 
   -Pleuropericarditis 
 
35 
0 
0 
0 
0 
0 
0 
 
0 
37 
8 
4 
3 
1 
1 
Systemic disease 
   -HIV 
   -Vasculitis 
   -Collagen disease 
   -Steroid therapy 
   -Diabetes  
 
9 
0 
0 
1 
1 
 
7 
1 
1 
2 
3 
Clinical picture 
   -Acute (< 2 weeks) 
   -Sub-acute 
 
9 
32 
 
26 
22 
Pulmonary infiltrate 
   -Alveolar 
   -Interstitial 
   -Pleural effusion 
   -No infiltrate 
 
20 
11 
4 
1 
 
32 
11 
8 
12 
Basal Ca-125 level (IU/ml) 
   -Mean (± DE) 
   -Median 
   -Range  
 
104.9 (± 136.1) 
46 
10-500 
 
27.1 (± 19.7) 
24 
5-123 
Ca-125 level during therapy (2-4 month (IU/ml) 
   -Mean (± DE) 
   -Median 
   -Range 
 
59.5 (± 88.5) 
31 
13-63 
 
* COPD: chronic obstructive pulmonary disease. 
# All three patients responded to clarithromycin and a probable atypical pneumonia diagnosis was established. Ca-125  The Open Respiratory Medicine Journal, 2009, Volume 3    125 
  Ca-125 serum levels were significantly higher in patients 
with tuberculosis (mean ± SD, 104.9 ± 136.1 IU/mL, 
median: 46 IU/mL) than in the control group (mean±SD, 
27.1 ± 19.7 IU/ml, median: 24). ROC curve analysis showed 
a relationship between the diagnosis of TB and Ca-125 
values, with an AUC of 0.77 (95% asymptotic confidence 
interval: 0.66-0.87). The optimal cut-off value of Ca-125 for 
TB diagnosis was 32.5 IU/ml, with a sensitivity, specificity, 
positive predictive value and negative predictive value of 
68.6%, 77.8%, 66.7% and 79%, respectively. 
  A 68.6% of patients with pulmonary tuberculosis showed 
Ca 125 serum levels >32.5 IU/ml vs a 22% of patients with 
other pulmonary infections (p<0.01). No significant 
association was found between Ca 125 levels >32.5 IU/mL 
and gender, clinical and radiological presentation, including 
pleural effusion, extra pulmonary manifestations and HIV 
infection. 
  Ca 125 levels were determined in 10 patients with 
pulmonary TB during follow-up, after 2 to 4 months of 
therapy. The mean Ca 125 value was 59.5 (± 88.5) IU/ml 
and the median was 31 (range: 13 to 63) (Table 1). Fig. (1) 
shows the decrease of Ca 125 values observed in these 10 
patients during TB therapy. 
(IU/ml) 
Fig. (1). Basal and post-therapy (2-4 months) Ca-125 levels in 10 
patients with pulmonary tuberculosis. 
DISCUSSION 
  Ca 125 antigen is a large molecular-weight glycoprotein 
synthesized by different cells originating from the celomic 
epithelium. Although classically it has been used to monitor 
the course of ovarian epithelial cancer, there are other 
circumstances associated with high serum Ca 125 levels, 
which decrease the sensitivity and specificity of the test 
when used generally/non-specifically. Ca 125 levels have 
been determined in mesothelial cell lines by immuno-
histochemistry methods and in bronchial epithelial cells by 
immunoperoxidase stained techniques [16]. If these cells are 
activated by physiological or pathological reactions, such as 
menstruation, inflammation or cancer, Ca 125 is released. 
  Many malignant processes have been associated with 
high serum Ca 125 levels: including several tumors, other 
than ovarian epithelial cancer, such as pulmonary, 
hepatobiliary, gastric, colorectal, pancreatic neoplasias and 
non-Hodgkin lymphomas with mediastinal and/or abdominal 
location [17-20]. Other circumstances related with the   
 
 
stimulus of mesothelial cells, such as peritoneal dialysis, 
pelvic inflammatory disease, endometriosis, pancreatitis and 
autoimmune disorders have also been associated with 
elevated serum Ca 125 levels [7, 21-23]. Mirales et al. have 
reported increased Ca 125 levels (>35 IU/ml) in patients 
with previous surgery, pulmonary disease, heart failure, 
cirrhosis and intrabdominal disease [24]. 
  Other studies have confirmed high serum Ca 125 levels 
in tuberculosis, mainly in extrapulmonary locations with 
abdominal involvement [10,11,25-30]. Some authors have 
reported elevated serum Ca 125 levels in benign pulmonary 
diseases, including tuberculosis [31]. 
 Ronay et al. demonstrated the expression of Ca-125 in 
the proximity of tuberculous granulomas using an immuno-
histochemical method in two patients with peritoneal TB 
probably due to proliferation of mesothelial cells [32]. 
Another study, using anti Ca 125-labeled specific antibodies 
confirmed positive capture of antibodies on giant epithelioid 
cells in patients with pleural and peritoneal TB [33]. 
  A small number of studies have analyzed the role of 
serum Ca 125 in patients with pulmonary TB. A case-control 
study comparing patients with active tuberculosis with 
patients with cured tuberculosis confirmed a significant 
elevation of serum Ca 125 levels in patients with TB and a 
normalization of these levels during therapy [34]. Mean Ca 
125 levels in patients with tuberculosis were significantly 
higher than that observed in patients with past tuberculosis, 
or healthy patients. Moreover, a significant reduction of Ca 
125 levels was observed in patients with pulmonary 
tuberculosis during therapy. For a Ca 125 value of 31 IU/ml, 
authors confirmed a sensitivity and specificity of 97.5% and 
100%, respectively [34]. This normalization of Ca 125 
values during therapy of patients with pulmonary 
tuberculosis has also been observed in other studies 
[12,13,35,36]. 
  An important contribution of the present study is the 
potential role of Ca 125 measurements in patients with fever 
and pulmonary infiltrates of unknown aetiology, with 
elevated levels supporting a diagnosis of pulmonary 
tuberculosis in patients where the disease was suspected but 
respiratory samples had negative AFB stains. In the present 
study AFB stains were positive in sputum in all but one case; 
in this case basal Ca-125 level was 150 IU/ml. 
 Aoki  et al., demonstrated a sensitivity, specificity and 
accuracy of 100%, 75% and 84%, respectively, for serum Ca 
125 >35 IU/ml in patients with pleural tuberculosis [3]. 
Patients with other pleural pathologies, such as mesothelial 
neoplasias, empyemas, para-pneumonic pleural effusions or 
autoimmune disorders, were used as controls. Results 
obtained with serum Ca 125 levels were similar or better 
than those obtained using pleural ADA (adenosine 
deaminase) levels >45 IU/ml, with a sensitivity, specificity 
and accuracy for this test of 81.8%, 89.3% and 87.2%, 
respectively [3]. In the present study the number of patients 
with pleural effusion was low (4 in the TB group and 8 in the 
control group), but all patients with tuberculosis and pleural 
effusion had Ca 125 serum levels >35 IU/ml (data not 
shown). 
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  The present report has several limitations. This is a 
retrospective study and a specific protocol focusing on the 
relationship between Ca-125 levels and tuberculosis was not 
applied. Control patients were not homogeneous and 
included a miscellaneous of patients with a diagnosis of 
bacterial pneumonia or other pulmonary infections. A low 
number of patients with pleural effusion were included and a 
specific analysis focused in these patients was not possible. 
Patients with lung infiltrates related with oncologic process, 
but unsuspected at admission, were excluded. Finally, in 
only 10 patients a second determination of Ca 125 serum 
level was available for outcome analysis. 
  In conclusion, the present study seems to confirm by 
mimicking the results of other similar studies, that serum Ca 
125 levels in patients with pulmonary tuberculosis are 
significantly higher than that observed in patients with other 
causes of pulmonary infection. Ca 125 measurement may be 
recommended if pulmonary tuberculosis is suspected and 
AFB stain of respiratory samples is negative or not available. 
The decrease in levels during therapy may be useful to 
monitor patients with pulmonary tuberculosis. 
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